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Coronary CT angiography has been increasingly used in the diagnosis of coronary artery 
disease due to rapid technological developments, which are reflected in the improved 
spatial and temporal resolution of the images.  High diagnostic accuracy has been 
achieved with 64- and more slice CT scanners and in selected patients, coronary CT 
angiography is regarded as a reliable alternative to invasive coronary angiography.  
Although the tremendous contributions of coronary CT angiography to cardiac imaging 
are acknowledged, appropriate use of cardiac CT as the first line technique by physicians 
has not been well established.  Optimal selection of cardiac CT is essential to ensure 
acquisition of valuable diagnostic information and avoid unnecessary invasive procedures.  
This is of paramount importance since cardiac CT not only involves patient risk 
assessment, prediction of major cardiac events, but also impacts physician decision- 
making on patient management.  Applications of CT in cardiac imaging include coronary 
artery calcium scoring for predicting the patient risk of developing major cardiac events, 
followed by coronary CT angiography which is commonly used to determine the 
diagnostic and prognostic accuracy in the coronary artery disease.  This review presents 
an overview of the applications of CT in cardiac imaging in terms of coronary calcium 
scoring and coronary CT angiography.  Judicious use of both cardiac CT tools will be 
discussed with regard to their value in different patient risk groups with the aim of 
identifying the appropriate criteria for choosing a cardiac CT modality.  An effective 
diagnostic pathway is finally recommended to physicians for appropriate selection of 
cardiac CT in clinical practice. 
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Coronary artery disease (CAD) is the leading cause of mortality and morbidity in 
developed countries.  The diagnosis and management of CAD is increasingly dependent 
on non-invasive imaging modalities.  Recent technological advances have led to a 
considerable increase in image quality for coronary imaging using multislice CT. 1-3  
Numerous studies have shown that coronary CT angiography (CCTA), as a less-invasive 
alternative to coronary angiography, has a high diagnostic accuracy for the detection of 
significant CAD (≥50% lumen stenosis) when compared to invasive coronary 
angiography. 3-9  High quality multislice CT (64-slice and higher) is not only able to 
provide reliable information on coronary luminal changes, but also has the potential to 
visualise coronary artery wall morphology, characterise atherosclerotic plaques and 
identify non-stenotic plaques that may be undetected by conventional coronary 
angiography.  Studies have shown that CCTA demonstrates high prognostic value in 
CAD, as it is able to differentiate low-risk from high-risk patients 10-12, with very low rate 
of adverse cardiac events occurring in patients with normal CCTA, and significantly high 
rate of these events in patients with obstructive CAD. 
It has been a regular procedure to perform both coronary artery calcium (CAC) scoring 
and CCTA for diagnosis in patients with suspected CAD.  Results dealing with the 
incremental prognostic value of CAC scoring used in combination with CCTA have 
recently been published. 13  Although satisfactory results have been achieved in these 
studies, with strengths and weaknesses being addressed, very few studies have 
specifically examined the clinical applications of CCTA in the particular target 
population, or risk stratification and assessment with regard to the judicious use of 
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CCTA.14-16  Identification of the exact role of CCTA in patients from different risk 
groups is clinically significant as this could lead to unnecessary examinations due to the 
fact that multislice CT is an imaging modality with high radiation dose.  In addition, 
appropriate selection of CCTA is of paramount importance for physicians to choose 
CCTA as a gatekeeper for further diagnostic testing.  This article explores how 
physicians should use multislice CT wisely in terms of the clinical value of coronary 
calcium scoring to predict the extent of coronary artery disease or cardiac events, and 
CCTA in patients from different risk groups with a focus on low to intermediate risk 
patients.  The potential value and benefits of CCTA in asymptomatic patients are also 
explored.  Finally, this articles looks at when physicians should request CCTA 
appropriately from a clinical point of view by following the appropriate imaging 
pathways. 
Current status of coronary CT angiography in coronary artery disease 
With recent progress in the technical developments of multislice CT scanners, images can 
be acquired in a very short time with very high spatial resolution.  In particular, the 
development of 64- or more slice CT scanners allows acquisition of cardiac images with 
a temporal resolution that is a fraction of the length of the cardiac cycle with an isotropic 
volume resolution of less than 0.5 mm. 9, 17  Non-diagnostic CCTA studies have 
decreased from 15-25% with the early generation of 4- and 16-slice CT scanners to less 
than 10% with 64-slice CT scanners. 17, 18  The cost of performing a CCTA examination 
is much lower than that of an invasive coronary angiography, and is equivalent to an 
imaging stress test.  Unlike invasive coronary angiography, which is associated with 
procedure-related complications, CCTA is a less invasive modality with very rare 
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occurrence of complications resulting from CT examinations.  Consequently, there has 
been extensive interest in the clinical application of CCTA in the evaluation of patients 
with suspected CAD. 
Most studies have reported the diagnostic accuracy of CCTA by coronary artery segment, 
coronary artery and per patient assessment.  Several meta-analyses of studies on the use 
of 64-slice CT reported mean sensitivities and specificities ranging from 85% to 99%, 
and 86% to 96%, respectively. 3, 8, 19, 20  Given the dependence of positive predictive 
value and negative predictive value on the prevalence of disease, the relatively high 
prevalence of significant CAD as determined by invasive coronary angiography in many 
of these selected study populations compared to the general population raises a concern 
in appraising the value of CCTA in clinical practice.  It has been shown that significant 
statistical heterogeneity exists among published studies, with smaller studies reporting 
higher diagnostic accuracy of CCTA in CAD. 21  Two recent multicentre studies 
discussed several methodological limitations of CCTA, as patients with high calcium 
scores were excluded from the analysis of one study, while in another study, no segments 
were excluded from the analysis despite high calcium scores, 4, 6  Therefore, reports of the 
diagnostic value of CCTA in CAD in the literature need to be interpreted with caution. 
Coronary artery calcium scoring –predictive value in CAD 
Quantifying the amount of coronary artery calcium with unenhanced CT calcium scoring 
has been widely accepted as a reliable non-invasive technique for screening risk of future 
cardiac events 22, 23, and is usually quantified by using the Agatston score or scores such 
as the volume score or calcium mass. 24-26  Clinical application of CAC has been 
supported by evidence showing that absence of calcium reliably excludes obstructive 
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coronary artery stenoses 27, and that the amount of CAC is a strong predictor for risk 
assessment of myocardial infarction and sudden cardiac death, independent of 
conventional coronary risk factors. 28-30  However, the prognostic value of CAC depends 
on the risk groups as to whether patient risk is reclassified and patient management can 
be changed based on CAC scores when compared to traditional risk assessments. 31  The 
Framingham risk score is one of the most commonly used risk-estimation systems, which 
enables clinicians to estimate cardiovascular risk in asymptomatic patients.  It is 
calculated using traditional risk predictors, including age, gender, total cholesterol, high-
density lipoprotein cholesterol, smoking status, and systolic blood pressure, and is 
represented as a 10-year risk score for the prediction of coronary heart disease events. 32  
However, there is growing evidence to show that these traditional risk assessment 
methods, based on risk factor analysis, have significant limitations when used to guide 
individual patient therapy. 32-34  CAC score by multislice CT has been increasingly used 
as an additional assessment tool to evaluate the risk of developing major cardiac events in 
asymptomatic and symptomatic patients. 
Coronary artery calcium scoring–predictive value in asymptomatic patients 
In asymptomatic individuals, zero CAC is associated with a very low (<1% per year) risk 
of major cardiac events over the next 3-5 years, whereas in asymptomatic patients with 
extensive coronary calcification, the major cardiac events have been reported to be 
increased by up to 11-fold. 35-37  Several large population-based studies have reported that 
in asymptomatic patients without known CAD, CAC is predictive of future cardiac 
events above and beyond traditional risk factors 38-40.  The recent population-based multi-
ethnic study of atherosclerosis, conducted in 6,722 asymptomatic patients belonging to 
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four racial ethnic groups and followed for 3.8 years, showed a significant difference in 
the prevalence of CAC among different ethnic groups.  Nonetheless, CAC has 
demonstrated incremental prognostic value over traditional risk factors, with a seven-fold 
increase in the incidence of cardiac events for Agatston scores >100 when compared with 
patients with zero CAC. 38 
Other studies evaluating the prognostic value of the measurement of CAC have shown 
that coronary calcification is predictive of cardiac events in asymptomatic patients with 
different age groups. 39-41  LaMonte et al. in their study consisting of nearly 11,000 
patients ranging from 22 to 96 years of age who underwent a screening medical 
examination, reported increased cardiac events in patients with coronary calcium scores 
of 400 or more during a mean follow-up of 3.5 years. 40  In the Prospective Army 
Coronary Calcium Project among men and women 40 to 45 years of age, Talyor et al. 
concluded that the presence of coronary calcium was associated with an increase in the 
risk of coronary events by a factor of 12 during 3 years of follow-up. 39  Similarly, higher 
calcium scores were found to be associated with the relative risks of coronary events in 
the population-based Rotterdam Study of elderly asymptomatic patients. 41 
Coronary calcium score– prognostic value in symptomatic patients 
Coronary calcification is considered only marginally related to the degree of coronary 
stenosis and it is well known that both obstructive and non-obstructive CAD can occur in 
the absence of calcification. 42-44  Significantly, coronary stenoses are frequently found to 
be non-calcified, and highly calcified plaques are frequently non-obstructive.  Thus, the 
value of a zero or low calcium score (a low coronary calcium score is defined as an 
Agatston score of 1 to 100 because a coronary calcium score of 100 is often used as a cut-
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off point for risk assessment) in symptomatic patients remains unclear.  Several studies 
have reported the presence of obstructive non-calcified plaque in up to 8.7% of 
symptomatic patients with zero or low calcium score. 45-47  The question has been raised 
as to whether only using CAC score is a reliable tool of determining the extent of CAD, 
since non-calcified coronary artery plaque may not be detected.  Cheng et al. reported 
that low but detectable CAC scores are less reliable in predicting plaque burden due to 
their association with high overall non-calcified coronary artery plaque. 45  They 
concluded that low CAC scores are significantly less predictive of prevalence or severity 
of underlying non-calcified coronary plaque. 
It has been recently suggested in some studies that coronary CT calcium score assessed 
with unenhanced CT may be supported by CCTA, or CCTA may be performed alone 
with the aim of acquiring more diagnostic information. 48-50  CCTA allows not only 
visualisation of the vessel lumen, but also of the vessel wall, including composition of 
atherosclerotic plaque (calcified versus non-calcified or mixed type of plaques).  
However, the contrast enhancement in the coronary artery vessels may obscure detection 
of plaque, especially the presence of extensively calcified plaques, and thus may obviate 
reliable measurements of plaque density.  CCTA was found to underestimate higher 
Agatston scores. 48  It has been reported in that study that CCTA allows for the detection 
of CAC with high accuracy, as well as good correlation with unenhanced CT calcium 
score.  In contrast, in patients with zero or low calcium score, CCTA was found to 
provide additional valuable information on patient management as CCTA detected 
obstructive coronary lesions in 7% of patients with a zero score and in 17% with a low 
CAC score.  Their study indicated that in symptomatic patients with a zero or low CAC 
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score on CT CAC scoring can be used to exclude an acute or long-term coronary 
syndrome, whereas CCTA is recommended as the non-invasive test of choice in these 
patients. 48  Similarly, van Werkhoven et al. in their recent report showed that CCTA 
provided additional prognostic information regarding stenosis severity and plaque 
composition when compared to CAC score for risk stratification in patients with 
suspected CAD.  Their study involved analysis of plaque composition with CCTA, and 
results showed that the number of segments with non-calcified plaques and the number of 
segments with mixed plaques was found to be independently associated with increased 
risk for adverse cardiac events. 50 
Coronary CT angiography in high-risk patients 
The pre-test probability of CAD may have a significant impact on the diagnostic 
performance of the CT scan.  Pre-test probability or likelihood is defined according to 
Diamond and Ferrester criteria, which are based on age, gender and symptomatic status. 
51  Intermediate likelihood is defined as a pre-test probability between 13.4% and 87.2%, 
while low and high pre-test probability are defined as less than 13.4% and more than 
87.2%, respectively.  It is noticed that the diagnostic performance of CCTA is different in 
patients from different risk groups.  The diagnostic accuracy of CCTA has been 
extensively studied in populations with a high pre-test likelihood for CAD. 17-20  However, 
this population is unlikely to benefit from CCTA because most patients require invasive 
coronary angiography for the purpose of revascularisation.  Meijboom et al. in their 
prospective study observed that, in patients with a high pre-test likelihood for CAD, 
interpretations using CCTA failed to significantly change the post-test probability of 
significant CAD.  Thus, normal findings of CCTA did not result in a sufficient reduction 
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of the post-test probability to reliably rule out the presence of significant CAD.  These 
data indicate that the majority of these symptomatic patients are likely to proceed to 
invasive coronary angiography despite the negative CCTA findings.15  CCTA is 
considered to be of limited clinical value in the evaluation of the high pre-test probability 
group.  In patients with a high pre-test likelihood for significant stenosis, functional 
evaluation, such as myocardial perfusion imaging, may be more relevant than CCTA to 
determine the need for revascularisation. 
Coronary CT angiography in low- and intermediate- risk patients 
In contrast to the high pre-test probability group, patients with an intermediate or low 
pre-test likelihood for CAD might receive more benefit from CCTA.  A very high 
negative predictive value (>99%) of CCTA reliably rules out the presence of significant 
CAD and can be used as a highly effective gatekeeper for invasive coronary angiography. 
14, 52, 53  Thus, when CCTA is used in a patient population with a low or intermediate pre-
test likelihood, the need for additional imaging will be restricted to those patients with an 
abnormal finding from CCTA.  Consequently, the use of CCTA could avoid invasive 
coronary angiography in most patients.  This concept is also supported by relevant data 
about cost-effectiveness.  Min et al. investigated the value of CCTA as a first line test 
compared to myocardial perfusion imaging using single photon emission computed 
tomography (SPECT) in patients with a low to intermediate pre-test likelihood.  They 
concluded that lower referral rates to invasive coronary angiography and lower healthcare 
costs were observed in their low-risk group. 54 
Diagnostic value of coronary CT angiography in the detection of atherosclerosis in low- 
to intermediate-risk groups has been confirmed in a latest study performed by 64-slice 
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CT compared to myocardial perfusion imaging.  Iwasaki et al. in their study used 64-slice 
CT to detect subclinical atherosclerosis in 415 asymptomatic patients with more than 
95% belonging to low- and intermediate-risk groups. 55   Their results showed very high 
prevalence (71%) of subclinical atherosclerosis in patients with low to intermediate risk 
patients, with one-fifth of them having significant coronary stenosis.  This is supported 
by other studies showing the high prevalence of atherosclerosis.  Hausleiter et al. 46 
reported the prevalence of coronary plaques was 67.1%, in their study comprising of 161 
patients with an intermediate risk for coronary artery disease.  Choi et al. studied 1000 
middle-aged asymptomatic patients with 64-slice CT and noticed the prevalence of 22% 
atherosclerotic plaques in these patients. 56  These studies further testified that coronary 
CT angiography is a valuable imaging modality for detection of atherosclerotic changes 
in the low- to intermediate-risk patients. 
Coronary CT angiography in asymptomatic patients 
Despite the high diagnostic accuracy of coronary artery stenosis and prognostic power of 
CCTA in symptomatic patients, to date there have been very limited publications 
evaluating the prognostic potential of CCTA in asymptomatic patients.  Although only 
limited data are available in asymptomatic patient populations, it is possible that CCTA is 
valuable for risk stratification in these patients, since CCTA can be used to detect 
atherosclerosis for long-term risk assessment. 57-59  The prevalence of atherosclerosis was 
reported to be 22% in a recent study consisting of 1,000 asymptomatic individuals 
undergoing CCTA, with 5% and 2% being observed in ≥50% CAD and ≥75% CAD, 
respectively. 57  Cardiac events occurred in 1.5% of individuals during a follow-up of 17 
months, all of whom had atherosclerosis on CCTA.  These data indicate that CCTA is 
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currently not acceptable as a general screening tool and CAC score testing may be a 
preferable option.  However, non-invasive CCTA may potentially be used as a test in the 
workup of asymptomatic individuals with cardiac risk characteristics. 57-60 
It has been recently reported that performing CCTA before invasive coronary 
angiography is a cost-effective strategy in the management of patients without symptoms 
who have positive stress rest results. 59  It is generally believed that a patient at low risk 
who has a positive stress test result (such as treadmill ECG studies, stress 
echocardiography, and radionuclide stress studies) is often referred for cardiac 
catheterisation, especially when the positive stress test result is obtained in a preoperative 
workup.  Halpern et al. in their study using decision tree analysis reported that when a 
patient with an expected CAD prevalence of less than 85% is found to have a positive test 
result, CCTA is a less expensive alternative to invasive coronary angiography.59  
Although most patients undergo screening for CAD with stress tests to obtain functional 
and perfusion information which is not available with CCTA, a meta-analysis on more 
than 35,000 patients with coronary angiography as the reference standard showed that 
only average sensitivity and specificity was achieved with stress echocardiography and 
SPECT.61  Thus, the use of CCTA in asymptomatic patients can avoid unnecessary 
invasive cardiac angiography procedures. 
Coronary CT angiography–radiation dose issue 
Radiation exposure associated with coronary CT angiography has increased substantially 
over the past two decades and it is a major concern that needs to draw attention of both 
clinicians and manufacturers.  The general view about radiation dose is that coronary CT 
angiography is associated with a risk of cancer development.  The recent Biological 
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Effects of Ionising Radiation (BEIR) VII provides a framework for estimating cancer risk 
associated with radiation exposure from ionising radiation.62  According to the report, it 
is estimated that 1 in 1000 people will develop cancer due to an exposure of 10 mSv.  
Brenner and Hall 63 estimated that approximately 1.5% to 2% of all cancers in the United 
States may be caused by radiation exposure from CT examinations.  Davies et al 
estimated that in the UK radiation from CT scans causes 800 cancers a year in women 
and 1300 in men. 64  Radiation exposure is especially important for young and female 
patients who present with atypical symptoms, but do not have high pre-test likelihood for 
having haemodynamically significant coronary stenosis.  A recent study reported that one 
in 270 women aged 40 years who undergo coronary CT angiography will develop cancer. 
65   
The number of CT scans is being increased significantly in Australia.  According to 
2008-09 Annual Report of the CEO of ARPANSA that the number of CT examinations 
in Australia increased greatly from 1994 (612,438 cases) to 2008 (1,935,802 cases) which 
is more than a 3-fold increase. 66  Coronary CT angiography should be performed with 
dose-saving strategies whenever possible to reduce the radiation dose to patients.  The 
reader is referred to several excellent review articles on dose reduction strategies 
currently recommended in coronary CT angiography. 9, 67-69  Judicious use of multislice 
CT in cardiac imaging by clinicians is essential to maximise its clinical applications 
while minimising the potential risk of radiation exposure. 
The basic principle of radiation protection is to keep radiation exposure “as low as 
reasonably achievable” (the ALARA principle).  Thus, if CAC scoring has no added 
benefit over CCTA in the routinely combined CAC scoring and CCTA scans, CAC 
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scoring may not be necessarily incorporated into the CCTA protocol.  Kwon et al. in their 
recent prospective study concluded that CCTA has positive correlation with CAC scores 
for prediction of major adverse cardiac events, and CCTA has better predictive value than 
CAC scoring in low-risk patients suspected of CAD.70  Their results showed no added 
benefit to the addition of CAC scoring to CCTA, although their study population was 
restricted to a relatively low-risk group.  Further studies based on multicentres with 
inclusion of large sample size are required to confirm their initial results. 
Summary and Conclusion 
The introduction of CCTA has significantly changed the clinical diagnostic approach to 
CAD.  There is no doubt that, in patients with clinical suspected CAD, CCTA plays a 
significant role in establishing or excluding the diagnosis.  With a very high negative 
predictive value, CCTA is widely regarded as a reliable technique in clinical practice to 
exclude significant CAD. 
Use of CCTA for diagnosis and risk assessment in patients with low or intermediate risk 
or pretest probability for coronary artery disease is favourably preferred, whereas in high-
risk patients, CCTA is less favourably recommended.  Use of non-contrast CT for 
coronary artery calcium scoring is considered an appropriate approach in low- and 
intermediate-risk patients for prediction of cardiac events, while in symptomatic or high- 
risk patients, its predictive value is less reliable due to high prevalence of non-calcified 
plaques.  Appropriate selections of cardiac CT will have a significant impact on physician 
decision-making and performance that will guide appropriate patient management 
strategies.  The flow chart (Figure 1) recommends the CT imaging pathways for 
physicians to choose multislice CT appropriately in patients with suspected coronary 
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artery disease and within different pre-test probabilities or risk groups.  It is expected that 
it will assist physicians, particularly cardiologists, to make judicious use of cardiac CT in 
their clinical practice. 
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Figure legend 
Figure 1. Flow chart shows the imaging pathways for appropriate selection of multislice 
CT in patients with suspected CAD. CAD-coronary artery disease, CCTA-coronary CT 
angiography, CAC-coronary artery calcium, MI-myocardial infarction. 
 
